Samsung Securities Faces Delays in Commercial Paper Business Approval

Reporter Paul Lee / approved : 2026-01-13 09:44:32
  • -
  • +
  • 인쇄

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Paul Lee] Samsung Securities is facing delays in securing regulatory approval to enter the commercial paper (CP) issuance business, even as competitors move ahead with full-scale operations.

According to the financial investment industry on Jan. 12, Samsung Securities has yet to receive approval from the Financial Services Commission, while rivals that applied at the same time have already cleared the process. Among five brokerages—Kiwoom, Meritz, Samsung, Hana, and Shinhan Investment—that applied in the second half of last year, only Meritz Securities and Samsung Securities remain unapproved.

Commercial paper issuance allows securities firms to raise short-term funding by issuing notes backed by their own credit, with maturities of up to one year and sales capped at twice their equity capital. The system is favored for its relatively simple issuance process and funding flexibility.

Market watchers suggest that regulatory concerns over past improper sales practices may be weighing on Samsung Securities’ application, noting that related sanction risks may need to be resolved before approval is granted.

The approval process involves multiple steps, including document review, evaluation by an external advisory committee, on-site inspections, deliberation by the Securities and Futures Commission, and final approval at a regular meeting.

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

SK Hynix to Invest KRW 19 Trillion in 7th Advanced Packaging Facility in Cheongju2026.01.13
Korea Exchange to Launch Pre- and After-Hours Trading From June2026.01.13
KFTC Probes Coupang Over Alleged Bundling and Market Dominance Concerns2026.01.13
Celltrion’s Eyecare Biosimilar Faces Mixed European Court Rulings2026.01.13
Kyowon Group Confirms Cyberattack, Investigates Potential Data Breach2026.01.13
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사